Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[A point mutation in YY1-recognition site 2, which was previously shown to stimulate P97 3.5-fold, could be detected in the HPV 16 LCRs from both primary tumor and metastasis, indicating that the mutation is a stable characteristic of HPV 16 DNA associated with the individual cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[A point mutation in YY1-recognition site 2, which was previously shown to stimulate P97 3.5-fold, could be detected in the HPV 16 LCRs from both primary tumor and metastasis, indicating that the mutation is a stable characteristic of HPV 16 DNA associated with the individual cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP843456.RAS51AfU-8Q2msU0hggfk98gAfena45EV-hlKw7EazD3g130_assertion description "[A point mutation in YY1-recognition site 2, which was previously shown to stimulate P97 3.5-fold, could be detected in the HPV 16 LCRs from both primary tumor and metastasis, indicating that the mutation is a stable characteristic of HPV 16 DNA associated with the individual cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843456.RAS51AfU-8Q2msU0hggfk98gAfena45EV-hlKw7EazD3g130_provenance.
• assertion description "[A point mutation in YY1-recognition site 2, which was previously shown to stimulate P97 3.5-fold, could be detected in the HPV 16 LCRs from both primary tumor and metastasis, indicating that the mutation is a stable characteristic of HPV 16 DNA associated with the individual cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A point mutation in YY1-recognition site 2, which was previously shown to stimulate P97 3.5-fold, could be detected in the HPV 16 LCRs from both primary tumor and metastasis, indicating that the mutation is a stable characteristic of HPV 16 DNA associated with the individual cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A point mutation in YY1-recognition site 2, which was previously shown to stimulate P97 3.5-fold, could be detected in the HPV 16 LCRs from both primary tumor and metastasis, indicating that the mutation is a stable characteristic of HPV 16 DNA associated with the individual cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A point mutation in YY1-recognition site 2, which was previously shown to stimulate P97 3.5-fold, could be detected in the HPV 16 LCRs from both primary tumor and metastasis, indicating that the mutation is a stable characteristic of HPV 16 DNA associated with the individual cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1327281.RAVeitHTmNV8siBN5efw_7glkCk-AX3KhRPBCXhKMUZpo130_assertion description "[A point mutation in YY1-recognition site 2, which was previously shown to stimulate P97 3.5-fold, could be detected in the HPV 16 LCRs from both primary tumor and metastasis, indicating that the mutation is a stable characteristic of HPV 16 DNA associated with the individual cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1327281.RAVeitHTmNV8siBN5efw_7glkCk-AX3KhRPBCXhKMUZpo130_provenance.
• NP372583.RABDoXgMLqAdkdpUoEcIc42eNaBVNi1RwmJiuNOo0Xi9E130_assertion description "[A point mutation in YY1-recognition site 2, which was previously shown to stimulate P97 3.5-fold, could be detected in the HPV 16 LCRs from both primary tumor and metastasis, indicating that the mutation is a stable characteristic of HPV 16 DNA associated with the individual cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372583.RABDoXgMLqAdkdpUoEcIc42eNaBVNi1RwmJiuNOo0Xi9E130_provenance.
• NP652028.RAqGQXVgyKbcaFFxRZZLnWvx1rSH06gtA9GuI2lCGcIE8130_assertion description "[A point mutation in YY1-recognition site 2, which was previously shown to stimulate P97 3.5-fold, could be detected in the HPV 16 LCRs from both primary tumor and metastasis, indicating that the mutation is a stable characteristic of HPV 16 DNA associated with the individual cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP652028.RAqGQXVgyKbcaFFxRZZLnWvx1rSH06gtA9GuI2lCGcIE8130_provenance.
• NP1327283.RAo3eV8qCDtLck4KNXOdErB3vEBNn_uzQ-19VOjEU0S38130_assertion description "[A point mutation in YY1-recognition site 2, which was previously shown to stimulate P97 3.5-fold, could be detected in the HPV 16 LCRs from both primary tumor and metastasis, indicating that the mutation is a stable characteristic of HPV 16 DNA associated with the individual cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1327283.RAo3eV8qCDtLck4KNXOdErB3vEBNn_uzQ-19VOjEU0S38130_provenance.
• NP1327284.RAiRQD0rWWoi_sb5ZurcoCn32vN--u4gVke-hcVOFPQfI130_assertion description "[A point mutation in YY1-recognition site 2, which was previously shown to stimulate P97 3.5-fold, could be detected in the HPV 16 LCRs from both primary tumor and metastasis, indicating that the mutation is a stable characteristic of HPV 16 DNA associated with the individual cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1327284.RAiRQD0rWWoi_sb5ZurcoCn32vN--u4gVke-hcVOFPQfI130_provenance.
• NP898186.RAiRIps3HeJ10IM8J_EzB6id9pqosA4qYA5evra2yyyow130_assertion description "[A point mutation in YY1-recognition site 2, which was previously shown to stimulate P97 3.5-fold, could be detected in the HPV 16 LCRs from both primary tumor and metastasis, indicating that the mutation is a stable characteristic of HPV 16 DNA associated with the individual cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898186.RAiRIps3HeJ10IM8J_EzB6id9pqosA4qYA5evra2yyyow130_provenance.
• NP898210.RAtL3ma4QctbcPALxxy4pRY3L-7j1V5QolaIkJ23_88YE130_assertion description "[A point mutation in YY1-recognition site 2, which was previously shown to stimulate P97 3.5-fold, could be detected in the HPV 16 LCRs from both primary tumor and metastasis, indicating that the mutation is a stable characteristic of HPV 16 DNA associated with the individual cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898210.RAtL3ma4QctbcPALxxy4pRY3L-7j1V5QolaIkJ23_88YE130_provenance.
• NP372500.RAOzU6kDxNcKbWwpHEGF4sKn-sDLSXmh5GpRidO47fQx4130_assertion description "[A point mutation in YY1-recognition site 2, which was previously shown to stimulate P97 3.5-fold, could be detected in the HPV 16 LCRs from both primary tumor and metastasis, indicating that the mutation is a stable characteristic of HPV 16 DNA associated with the individual cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372500.RAOzU6kDxNcKbWwpHEGF4sKn-sDLSXmh5GpRidO47fQx4130_provenance.
• NP652009.RA6NXkQdWlgxAfFrnyYJG1GqMj1lqr9WxokbhSNsCvNEI130_assertion description "[A point mutation in YY1-recognition site 2, which was previously shown to stimulate P97 3.5-fold, could be detected in the HPV 16 LCRs from both primary tumor and metastasis, indicating that the mutation is a stable characteristic of HPV 16 DNA associated with the individual cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP652009.RA6NXkQdWlgxAfFrnyYJG1GqMj1lqr9WxokbhSNsCvNEI130_provenance.
• NP1327280.RAG7TB9A9n6n8qJbjiWZeALEZS0emfOMsZQtFqFIpskW4130_assertion description "[A point mutation in YY1-recognition site 2, which was previously shown to stimulate P97 3.5-fold, could be detected in the HPV 16 LCRs from both primary tumor and metastasis, indicating that the mutation is a stable characteristic of HPV 16 DNA associated with the individual cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1327280.RAG7TB9A9n6n8qJbjiWZeALEZS0emfOMsZQtFqFIpskW4130_provenance.
• NP843470.RAOtdUgt-O-z6WxVERwSfBbpXkkQe-tFi4kHhnTr1VSNk130_assertion description "[A point mutation in YY1-recognition site 2, which was previously shown to stimulate P97 3.5-fold, could be detected in the HPV 16 LCRs from both primary tumor and metastasis, indicating that the mutation is a stable characteristic of HPV 16 DNA associated with the individual cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843470.RAOtdUgt-O-z6WxVERwSfBbpXkkQe-tFi4kHhnTr1VSNk130_provenance.
• NP768792.RA75kjMuETE03D4Ald7tHlPfnngLLlGjmJnt60bDFkGMc130_assertion description "[A point mutation in YY1-recognition site 2, which was previously shown to stimulate P97 3.5-fold, could be detected in the HPV 16 LCRs from both primary tumor and metastasis, indicating that the mutation is a stable characteristic of HPV 16 DNA associated with the individual cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768792.RA75kjMuETE03D4Ald7tHlPfnngLLlGjmJnt60bDFkGMc130_provenance.
• NP768990.RA3Klcl6PCzKYKLnj2I5cU6UgJ18xZAPMiH928MMKiHA4130_assertion description "[A point mutation in YY1-recognition site 2, which was previously shown to stimulate P97 3.5-fold, could be detected in the HPV 16 LCRs from both primary tumor and metastasis, indicating that the mutation is a stable characteristic of HPV 16 DNA associated with the individual cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768990.RA3Klcl6PCzKYKLnj2I5cU6UgJ18xZAPMiH928MMKiHA4130_provenance.
• NP1327282.RA79jmrow1EuEmeEQWN2fTbVGdRYkkPO6gRa1CVu8f_ZM130_assertion description "[A point mutation in YY1-recognition site 2, which was previously shown to stimulate P97 3.5-fold, could be detected in the HPV 16 LCRs from both primary tumor and metastasis, indicating that the mutation is a stable characteristic of HPV 16 DNA associated with the individual cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1327282.RA79jmrow1EuEmeEQWN2fTbVGdRYkkPO6gRa1CVu8f_ZM130_provenance.